Randeep Guleria

WATCH | The rise in India’s Covid-19 caseload, coupled with a rise in influenza cases, has left many worried, especially since it’s difficult to differentiate between the two based on symptoms. Now that everyone is once again trying to figure out ways to prevent getting infected, Moneycontrol spoke with one of India’s top doctors -- Dr Randeep Guleria -- to understand whether it’s time to take a booster shot, how worried should we be the case surge, and what to expect in the near future.

Covid spike to stabilise in two weeks, need to assess vaccine efficacy, develop new shots: Dr Guleria

The former AIIMS director said the coronavirus would continue to mutate and become more infectious, and that the country will continue to see smaller waves in the coming months.

Former AIIMS director Randeep Guleria takes voluntary retirement

His five-and-a-half-year tenure as director of the institute ended on September 23 after which he had applied for VRS, which has been approved.

Covid in endemic phase, experts feel

Currently, the symptoms of Covid and influenza are very similar and can said to be a flu-like syndrome and the treatment essentially remains supportive, former AIIMS director and a professor of pulmonology at the hospital, Dr Randeep Guleria said.

People with low immunity are affected by mucormycosis, says AIIMS director Randeep Guleria

If symptoms persist for more than 12 weeks, it can be classified as a post-COVID syndrome, Guleria has said.

COVID-19 update | No evidence that children will be severely affected in third wave, says AIIMS director Dr Randeep Guleria

Guleria's comment comes a day after the Indian Academy of Paediatrics has said that though kids remain susceptible to COVID-19 infection, it is “highly unlikely that the third wave will predominantly or exclusively affect children”.

Black fungus is not a new infection but cases rising among COVID-19 patients, says AIIMS chief Randeep Guleria

The doctor said that misuse of steroids is a major cause behind this infection mucormycosis.

India will have large number of COVID-19 vaccine doses by August: Dr Randeep Guleria

By July-August we will have a large number of doses available, said AIIMS Director Dr Randeep Guleria.

COVID-19 vaccine should be able to give protection for 8-10 months: AIIMS director Randeep Guleria

The COVID-19 vaccine should be able to give good protection from the infection for eight to ten months and maybe, even more, Guleria said at an event organised by the IPS (Central) Association.

Need to find out if Kerala, Maharashtra have mutant coronavirus strain, says AIIMS chief

As per data shared by the Union Ministry of Health and Family Welfare, Kerala and Maharashtra together account for 71 percent of the total COVID-19 caseload of the past week.

Coronavirus Vaccine India | Easy to immunise children with intranasal COVID-19 vaccines, says AIIMS Director Randeep Guleria

AIIMS Director Dr Guleria explained: “COVID-19 vaccines for children may come later...Bharat Biotech is trying to get approved a nasal vaccine. Such vaccine will be very easy to be given to children as it is a spray and not a jab and hence compliance is more.”

COVID-19 cases in India to peak in June-July, no declining trend despite lockdown: AIIMS director

AIIMS Director Dr Randeep Guleria said: "Currently, the cases are continuing to grow at a flat rate, sometimes even more. So, it is very difficult to predict when the peak will come; but it is likely to peak around June or July."

Prez bestows Bharat Ratna on Malviya, Padma awards

Noted educationist and freedom fighter Madan Mohan Malviya was on Monday posthumously conferred the Bharat Ratna, country's highest civilian award, by President Pranab Mukherjee.